Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 11 | 2023 | 563 | 2.760 |
Why?
|
| Caenorhabditis elegans | 9 | 2023 | 246 | 2.750 |
Why?
|
| Gene Silencing | 6 | 2023 | 181 | 1.320 |
Why?
|
| RNA, Helminth | 4 | 2018 | 6 | 1.120 |
Why?
|
| RNA Interference | 3 | 2019 | 385 | 0.860 |
Why?
|
| Caenorhabditis elegans Proteins | 4 | 2023 | 124 | 0.800 |
Why?
|
| Ephrin-A4 | 1 | 2021 | 1 | 0.700 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2021 | 24 | 0.690 |
Why?
|
| Fungal Proteins | 3 | 2010 | 147 | 0.690 |
Why?
|
| Liquid Crystals | 1 | 2020 | 13 | 0.640 |
Why?
|
| Cytoplasmic Granules | 1 | 2020 | 99 | 0.630 |
Why?
|
| RNA, Fungal | 2 | 2010 | 43 | 0.620 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 73 | 0.610 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 172 | 0.610 |
Why?
|
| Carcinogenesis | 1 | 2021 | 235 | 0.590 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 329 | 0.590 |
Why?
|
| DNA Helicases | 3 | 2022 | 90 | 0.570 |
Why?
|
| Gene Targeting | 1 | 2018 | 78 | 0.540 |
Why?
|
| Databases, Genetic | 1 | 2019 | 284 | 0.530 |
Why?
|
| Software | 2 | 2019 | 698 | 0.530 |
Why?
|
| Transcriptome | 2 | 2022 | 769 | 0.520 |
Why?
|
| Binding Sites | 1 | 2019 | 1167 | 0.480 |
Why?
|
| Internet | 1 | 2018 | 340 | 0.470 |
Why?
|
| Neurospora crassa | 2 | 2010 | 9 | 0.390 |
Why?
|
| RNA, Messenger | 1 | 2019 | 2090 | 0.380 |
Why?
|
| Genome, Helminth | 1 | 2012 | 5 | 0.380 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2010 | 66 | 0.370 |
Why?
|
| Replication Protein A | 1 | 2010 | 16 | 0.330 |
Why?
|
| RNA, Double-Stranded | 1 | 2010 | 26 | 0.330 |
Why?
|
| Neurospora | 1 | 2010 | 6 | 0.320 |
Why?
|
| Ribonuclease III | 1 | 2010 | 17 | 0.320 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2061 | 0.320 |
Why?
|
| Germ Cells | 3 | 2022 | 134 | 0.290 |
Why?
|
| Animals | 11 | 2023 | 28891 | 0.280 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 3157 | 0.260 |
Why?
|
| DNA Damage | 1 | 2009 | 392 | 0.260 |
Why?
|
| RNA | 1 | 2010 | 605 | 0.250 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2023 | 124 | 0.240 |
Why?
|
| MicroRNAs | 1 | 2010 | 591 | 0.230 |
Why?
|
| Argonaute Proteins | 5 | 2023 | 12 | 0.220 |
Why?
|
| AC133 Antigen | 1 | 2021 | 10 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 256 | 0.160 |
Why?
|
| Hydrolysis | 1 | 2020 | 146 | 0.160 |
Why?
|
| DNA, Single-Stranded | 2 | 2010 | 97 | 0.150 |
Why?
|
| Mice, Nude | 1 | 2021 | 830 | 0.150 |
Why?
|
| Web Browser | 1 | 2019 | 5 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2021 | 706 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1124 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2023 | 523 | 0.140 |
Why?
|
| Workflow | 1 | 2019 | 80 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2018 | 47 | 0.140 |
Why?
|
| Transgenes | 1 | 2018 | 186 | 0.130 |
Why?
|
| Protein Binding | 1 | 2021 | 1560 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 314 | 0.130 |
Why?
|
| Cell Line | 1 | 2021 | 2537 | 0.130 |
Why?
|
| Exoribonucleases | 1 | 2016 | 9 | 0.120 |
Why?
|
| Computational Biology | 1 | 2018 | 586 | 0.110 |
Why?
|
| RNA Caps | 1 | 2012 | 8 | 0.100 |
Why?
|
| Transcription Initiation Site | 1 | 2012 | 47 | 0.100 |
Why?
|
| Epigenomics | 1 | 2012 | 109 | 0.090 |
Why?
|
| Ribonucleases | 1 | 2010 | 97 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2016 | 3040 | 0.080 |
Why?
|
| Templates, Genetic | 1 | 2009 | 33 | 0.080 |
Why?
|
| DNA, Ribosomal | 1 | 2009 | 55 | 0.080 |
Why?
|
| Mice | 2 | 2021 | 12537 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2021 | 9175 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 399 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1535 | 0.060 |
Why?
|
| Mutation | 2 | 2016 | 4374 | 0.050 |
Why?
|
| Middle Aged | 1 | 2021 | 28368 | 0.040 |
Why?
|
| Humans | 2 | 2021 | 96105 | 0.030 |
Why?
|
| Female | 1 | 2021 | 50028 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 102 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 360 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2012 | 49 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2012 | 62 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2090 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 996 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 1765 | 0.010 |
Why?
|